최소침습 녹내장 수술(MIGS) 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 수술 방법별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth & Trends:

The global minimally invasive glaucoma surgery (MIGS) devices market size is anticipated to reach USD 781.2 million by 2030, registering a CAGR of 5.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. The substantial factors propelling market growth include increasing awareness about minimally invasive surgery, technological advancements, the expanding geriatric population, and the continuous development of healthcare infrastructure.

An increasing number of medical device manufacturers are placing their focus on research and product development to introduce innovative products with greater precision and the potential to improve surgical outcomes. For instance, in August 2022, Glaukos received FDA clearance for the iStent infinite Trabecular Micro-Bypass System. The iStent Infinite is designed for use as a standalone procedure to lower elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma that remains uncontrolled despite previous medical and surgical treatments.

The development of new procedures, such as minimally invasive glaucoma surgery (MIGS), creates new opportunities in the market. Healthcare professionals increasingly prefer minimally invasive surgeries since they offer advantages such as smaller incisions, rapid wound healing, reduced pain, and smaller or no surgical scars. Smaller incisions & lower scope of complications can significantly reduce the overall surgery cost. According to the National Library of Medicine (NCBI), approximately 40,000 MIGS surgical procedures were performed in patients diagnosed with glaucoma in 2018. This minimally invasive surgery can reduce hospital stays, lowering the chance of patients contracting hospital-acquired infections. Shorter hospital stays also enable patients to return to their normal lives quicker.

The growing geriatric population, which is more susceptible to developing glaucoma, is expected to significantly contribute to the growth of the minimally invasive glaucoma surgery devices market. For instance, according to a Statistics Canada report, in 2022, about 7.32 million people, accounting for 18.8% of the general population, were aged 65 and above in Canada. As the elderly population continues to expand, there is a higher prevalence of age-related eye conditions, with glaucoma being one of the most common. Furthermore, the rising incidence of diabetes globally is expanding the population of individuals with glaucoma. Diabetes is a widely recognized risk factor for the onset and advancement of glaucoma. For instance, according to the international diabetes federation, in 2021 there were about 366 million adults with diabetes the number is further estimated to reach 783 million by 2045. Thus, the aforementioned factors contribute to the market growth.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Highlights:

• Based on product, the glaucoma drainage implant segment dominated the market with a revenue share of over 33.18% in 2023. Moreover, the stent segment is anticipated to grow at the fastest CAGR during the forecast period
• Based on surgery method, the trabecular meshwork bypass segment held the largest market share in 2023. The Schlemm's canal implants segment is expected to grow at the fastest CAGR during the forecast period
• Based on end-use, the hospitals segment captured most of the market share in 2023. Patient safety and surgical success are given top priority at hospitals, thus boosting segment growth
• North America dominated the market with a revenue share of above 35% in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising geriatric population and prevalence of diabetes
    • 3.2.1.2. Growing awareness regarding minimally invasive surgery method
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of alternative treatment methods
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Needle Holders Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Product Movement Analysis & Market Share, 2023 & 2030
• 4.3. Valves
  • 4.3.1. Valves Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Glaucoma drainage implant
  • 4.4.1. Glaucoma Drainage Implant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Glaucoma tube shunts
  • 4.5.1. Glaucoma tube shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Stents
  • 4.6.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Surgery Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Surgery Method Movement Analysis & Market Share, 2023 & 2030
• 5.3. Trabecular meshwork bypass
  • 5.3.1. Trabecular Meshwork Bypass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Suprachoroidal space implants
  • 5.4.1. Suprachoroidal Space Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Subconjunctival space implants
  • 5.5.1. Subconjunctival Space Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Schlemm's canal implants
  • 5.6.1. Schlemm's Canal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Gonioscopy-assisted transluminal trabeculectomy
  • 5.7.1. Gonioscopy-assisted Transluminal Trabeculectomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Endocyclophotocoagulation
  • 5.8.1. Endocyclophotocoagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: End-use Movement Analysis & Market Share, 2023 & 2030
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Ophthalmic clinics
  • 6.4.1. Ophthalmic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Regional Movement Analysis & Market Share, 2023 & 2030
• 7.3. North America
  • 7.3.1. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Egypt Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Key Company Profiles
  • 8.1.1. Participant's Overview
  • 8.1.2. Product Benchmarking
  • 8.1.3. Financial Performance
  • 8.1.4. Strategic Initiatives
    • 8.1.4.1. Alcon, Inc.
    • 8.1.4.2. Glaukos Corporation.
    • 8.1.4.3. Johnson & Johnson Vision
    • 8.1.4.4. AbbVie Inc. (Allergan Plc.)
    • 8.1.4.5. Corza Ophthalmology
    • 8.1.4.6. Carl Zeiss Meditec AG
    • 8.1.4.7. Katalyst Surgical
    • 8.1.4.8. Lumenis Ltd
    • 8.1.4.9. Ziemer Ophthalmic Systems AG
    • 8.1.4.10. Iridex Corporation.
• 8.2. Participant Categorization
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Strategy Mapping
• 8.5. List of Other Key Market Players